Teva Pharmaceutical Industries Ltd (TEVA)
$7.15 0.04 (0.56%)
4:01 EDT TEVA Stock Quote Delayed 15 Minutes
Previous Close $21.89
Market Cap 7.28B
PE Ratio -0.45
Volume (Avg. Vol.) 2,000
Day's Range 7.19 - 7.19
52-Week Range 6.07 - 24.41
Dividend & Yield 0.07 (1.01%)
TEVA Stock Predictions, Articles, and Teva Pharmaceutical Industries Ltd News
- From InvestorPlace
- From the Web
The J&J opioid ruling 2019 for the case in Oklahoma has been decided and it will have the company paying a fine to the state.
A portfolio should hold high-risk, high-reward plays. And these nine stocks to buy offer big risks and even bigger potential returns.
Teva, Take-Two, Beyond Meat, PaySign and Sogou were our top stock trades on Tuesday. Here's how to trade them.
Tesla, Teva, Abbott Labs, Invitae and the gold ETF were are top stock trades on Wednesday. Let's look at the setups heading into Thursday.
The stock charts of Ford, International Paper and LyondellBasell are each knocking on the door of major moves, if traders can take one more step.
Teva Pharmaceuticals (TEVA) stock is down more than 7% to start the week as the company continues to face lawsuits, leading to a downgrade.
The stock charts for H&R Block, Philip Morris and Twitter are knocking on the door of some trade-worthy moves.
Options trading was buzzing in Teva Pharmaceuticals, Advanced Micro Devices, and General Electric on Tuesday. Here are the metrics that matter moving forward.
The stock charts of HRL, JNPR and LLY stock are moving into the midpoint of the week on the cusp of something trade-worthy.
Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.
Zscaler, Uber, Amazon, Teva and the S&P 500 are our top stock trades to watch going into Tuesday. Buckle up with these charts.
Teva Pharmaceuticals news concerning allegations and a massive price fixing lawsuit are hitting TEVA stock hard on Monday.
Teva stock is only getting lukewarm love from analysts, but tacitly, these pros may be more optimistic than they're letting on.
TEVA stock has multiple headwinds, including high debt and weakeneing Copaxone sales. But TEVA should benefit from promising new products.
Teva Pharmaceutical earnings for the fourth quarter of 2018 has TEVA stock falling hard on Wednesday with an EPS miss for the period.
Options trading was buzzing in Netflix, Micron, and Qualcomm. Here are the metrics and levels that matter moving forward.
From Seeking Alpha
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!